Pharmac board chairman Steve Maharey is backing an early access scheme that would give patients access to new and emerging drugs faster.

Maharey told the Herald that while Pharmac's core business was sound, it was

A fast-moving issue

Advertisement
Advertisement

UK improves early access

New Zealand behind on new drugs

A national disgrace

More money for Pharmac means less for DHBS